| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABC-system in estimating pathologic response of neoadjuvant treatment of prostate cancer
|
Berkut, M.
|
|
|
|
S3 |
p. S173
|
artikel
|
| 2 |
Aberrant expression of B7H4 and PD1 in Indian Urinary bladder cancer patients: Potential targets for combinational blocking approach
|
Singh, P.
|
|
|
|
S3 |
p. S353
|
artikel
|
| 3 |
Accuracy of mpMRI in detecting lesion location in prostate cancer-inital experience
|
Parameswaran, M.
|
|
|
|
S3 |
p. S103-S104
|
artikel
|
| 4 |
Accuracy of novel urinary biomarker tests for diagnosis and surveillance of NMIBC: A systematic review, diagnostic test accuracy and network meta-analyses
|
Laukhtina, E.
|
|
|
|
S3 |
p. S397-S398
|
artikel
|
| 5 |
Acute scrotal pain and COVID-19 in a busy acute hospital in the UK
|
Ibrahim, M.
|
|
|
|
S3 |
p. S233
|
artikel
|
| 6 |
Acute toxicity in moderate hypofractionation with Simultaneous Integrated Boost (SIB) radiation therapy for prostate cancer: A prospective study
|
Kraja, F.
|
|
|
|
S3 |
p. S117
|
artikel
|
| 7 |
ADC map parameters at mpMRI predict unfavorable cribriform pattern in PCa patients
|
Bianchi, L.
|
|
|
|
S3 |
p. S235
|
artikel
|
| 8 |
Adjuvant hyperthermic intravesical chemotherapy in intermediate and high-risk non-muscle invasive bladder cancer
|
Magalhaes, J.C.
|
|
|
|
S3 |
p. S373
|
artikel
|
| 9 |
Adjuvant immunotherapy versus tyrosine kinase inhibitors in patients with high-risk renal cell carcinoma: A systematic review and network meta-analysis of oncologic and toxicity outcomes
|
Laukhtina, E.
|
|
|
|
S3 |
p. S333-S334
|
artikel
|
| 10 |
Adjuvant therapy with immune checkpoint inhibitors versus chemotherapy after radical surgery for urothelial carcinoma: A systematic review and network meta-analysis of oncologic and toxicity outcomes
|
Laukhtina, E.
|
|
|
|
S3 |
p. S385-S386
|
artikel
|
| 11 |
Advanced age and early androgen deprivation therapy increase survival at different stages of the treatment in castration resistant prostate cancer patients
|
Ojeda Claro, A.V.
|
|
|
|
S3 |
p. S296
|
artikel
|
| 12 |
Aesthetic and functional results after single- and double-stage resection and reconstruction of penile paraffinomas – Experience from two tertiary centers and a surgical management algorithm
|
Marín Martínez, F.
|
|
|
|
S3 |
p. S256
|
artikel
|
| 13 |
Albumin lymphocyte index is a better predictor of overall survival than neutrophil lymphocyte ratio in bladder cancer patients treated by radical radiotherapy
|
Davies, J.
|
|
|
|
S3 |
p. S233
|
artikel
|
| 14 |
Amplio platform for quality assurance and improvement in surgery
|
Mercader Barrull, C.
|
|
|
|
S3 |
p. S127-S128
|
artikel
|
| 15 |
Analysis of techniques, perioperative, functional and survival outcomes after robot assisted radical cystectomy and intracorporeal orthotopic ileal neobladder: Our experience
|
Agarwal, V.
|
|
|
|
S3 |
p. S219
|
artikel
|
| 16 |
Analytical and clinical validation of the trucheckTM platform for diagnostic triaging of symptomatic cases suspected of prostate cancer
|
Akolkar, D.
|
|
|
|
S3 |
p. S177
|
artikel
|
| 17 |
Androgen receptor inhibitors for non-metastatic castration-resistant prostate cancer: network meta-analysis
|
Mori, K.
|
|
|
|
S3 |
p. S166-S167
|
artikel
|
| 18 |
An early response to immunotherapy predicts higher overall survival and progression-free survival outcomes in metastatic renal cell carcinoma patients
|
Ojeda Claro, A.V.
|
|
|
|
S3 |
p. S336
|
artikel
|
| 19 |
A new prognostic tool for therapy-response in non-muscle invasive bladder cancer patients: The Bladder Outlet-Cancer Score (BOCS)
|
Di Gianfrancesco, L.
|
|
|
|
S3 |
p. S227
|
artikel
|
| 20 |
An extremely rare cause for erectile dysfunction and rare tumor entity in the lesser pelvis: The retropubic ganglion cyst
|
Bannowsky, A.
|
|
|
|
S3 |
p. S419
|
artikel
|
| 21 |
Anterior vs. posterior end-to-end anastomotic urethroplasty outcome in traumatic urethral stricture: A single-center experience
|
Irdam, G.A.
|
|
|
|
S3 |
p. S257
|
artikel
|
| 22 |
A phase 3, randomized, double-blind trial of nivolumab or nivolumab plus ipilimumab versus placebo in patients with localized renal cell carcinoma who underwent radical or partial nephrectomy and are at high risk of relapse (CheckMate 914)
|
Gruenwald, V.
|
|
|
|
S3 |
p. S331
|
artikel
|
| 23 |
A phase 3 study (COSMIC-313) of cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal cell carcinoma of intermediate or poor risk
|
Choueiri, T.
|
|
|
|
S3 |
p. S188
|
artikel
|
| 24 |
A phase 2 study of futibatinib plus pembrolizumab in patients (pts) with advanced or metastatic urothelial carcinoma (mUC)
|
Sonpavde, G.
|
|
|
|
S3 |
p. S383-S384
|
artikel
|
| 25 |
A phase 2 study of intrapleural instillation of the nivolumab in cancer patients with pleural effusion
|
Tsimafeyeu, I.
|
|
|
|
S3 |
p. S338
|
artikel
|
| 26 |
A randomized, double-blind, placebo-controlled, phase 3 trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring susceptible FGFR3 genetic alterations: PROOF 302
|
Schnabel, M.J.
|
|
|
|
S3 |
p. S370-S371
|
artikel
|
| 27 |
A real-life analysis on Adrenocortical Carcinoma (ACC) in Slovenia: Survival, prognostic factors and histopathological markers in primary and metastases
|
Bokal, U.
|
|
|
|
S3 |
p. S415-S416
|
artikel
|
| 28 |
Are confirmatory biopsies needed in patients on active surveillance who underwent upfront MRI with possible targeted biopsy?
|
Luiting, H.B.
|
|
|
|
S3 |
p. S88-S89
|
artikel
|
| 29 |
Arsenic Trioxide (NTAX-44)- induced anti-cancer activity in human Prostate adeno carcinoma cell line
|
Bendale, Y.
|
|
|
|
S3 |
p. S211
|
artikel
|
| 30 |
Assessing response to intravesical BCG induction in high risk bladder cancer patients with flexible cystoscopy is a safe and financially preferable option
|
Hamilton, D.
|
|
|
|
S3 |
p. S235
|
artikel
|
| 31 |
A study on the clinical outcome of abiraterone acetate in castration resistant prostate cancer patients
|
De Mendonça Macedo, A.
|
|
|
|
S3 |
p. S285
|
artikel
|
| 32 |
A subgroup analysis from the IMvigor130 study in patients with upper tract vs. lower tract locally advanced or metastatic urothelial carcinoma treated with atezolizumab plus platinum-based chemotherapy
|
Bamias, A.
|
|
|
|
S3 |
p. S92-S93
|
artikel
|
| 33 |
A surgeon feedback system (AMPLIO) for nerve-sparing radical prostatectomy assessing functional and oncological outcomes
|
Rivero Belenchón, I.
|
|
|
|
S3 |
p. S123
|
artikel
|
| 34 |
Augmented reality to guide intraoperative frozen section during robot-assisted radical prostatectomy
|
Bianchi, L.
|
|
|
|
S3 |
p. S247-S248
|
artikel
|
| 35 |
A Virtual Patient 2020 | multidimensional profile of patients with prostate cancer from physicians’ perspective in the era of the COVID-19 pandemic
|
Chłosta, P.
|
|
|
|
S3 |
p. S253
|
artikel
|
| 36 |
Cabazitaxel as 3rd-4th line of treatment in castration-resistant metastatic prostate cancer - assessment of the impact of prior treatments on survival outcomes
|
Valente, A.D.C.
|
|
|
|
S3 |
p. S294
|
artikel
|
| 37 |
Can preoperative Neutrophil/Lymphocyte Ratio (NLR) predict Grade Group Upgrading (GGU) at radical prostatectomy?
|
Erdem, S.
|
|
|
|
S3 |
p. S118-S122
|
artikel
|
| 38 |
CERES, a retrospective study of patients with advanced renal cell carcinoma who received cabozantinib as part of the UK Managed Access Program: Baseline characteristics and clinical outcomes
|
Szabados, B.
|
|
|
|
S3 |
p. S190-S191
|
artikel
|
| 39 |
Characteristics of patients with non-regional Lymph Nodes (LN) Metastases (Mts) from Prostate Cancer (PCa)
|
Puchinskaya, M.
|
|
|
|
S3 |
p. S138
|
artikel
|
| 40 |
Characteristics of transforming growth factor beta receptor type II (TGFβRII) membranous expression in prostate cancer (PCa)
|
Puchinskaya, M.
|
|
|
|
S3 |
p. S266
|
artikel
|
| 41 |
Characterization and outcome of patients with testicular germ cell tumours treated in a comprehensive cancer centre
|
Moreira, I.
|
|
|
|
S3 |
p. S347
|
artikel
|
| 42 |
Choline PET guided salvage intensity modulated radiation therapy (sIMRT) for Oligometastatic Castrate Resistant Prostate Cancer (OCRPC)
|
Gits, H.C.
|
|
|
|
S3 |
p. S145
|
artikel
|
| 43 |
Clinical effectiveness of two-step population-based screening for urothelial malignancies during pandemic
|
Kuć, K.
|
|
|
|
S3 |
p. S354-S355
|
artikel
|
| 44 |
Clinical trial protocol for PSMA-SELECT: Dutch National Randomized study of PSMA-PET/ CT as a triage tool for pelvic lymph node dissection in prostatectomy patients
|
Wever, L.
|
|
|
|
S3 |
p. S274-S276
|
artikel
|
| 45 |
Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: Analysis of published case series data
|
Grogg, J.B.
|
|
|
|
S3 |
p. S243
|
artikel
|
| 46 |
C-Met receptor-mediated fluorescence-guided surgery in penile cancer patients
|
De Vries, H-M.
|
|
|
|
S3 |
p. S247
|
artikel
|
| 47 |
Comparative study of perioperative and survival outcomes after Video Endoscopic Inguinal Lymphadenectomy (VEIL) and Open Inguinal Lymph Node Dissection (OILND) in the management of inguinal lymph nodes in carcinoma penis
|
Dev, P.
|
|
|
|
S3 |
p. S248-S249
|
artikel
|
| 48 |
Comparing adverse effects, short term outcomes, and cost implications of Hyperthermic Intravesical Chemotherapy (HIVEC) with mitomycin-C and intravesical BCG instillation (Moscow-I strain) in the management of intermediate and high-risk NMIBC
|
Dev, P.
|
|
|
|
S3 |
p. S220-S222
|
artikel
|
| 49 |
Comparing the characteristics of advanced Prostate Cancer (PC) patients with and without DNA Damage Repair mutations (DDRm): A systematic review
|
Castro, E.
|
|
|
|
S3 |
p. S154
|
artikel
|
| 50 |
Comparing the urothelial cancer detection rates in patients on anticoagulants and not on anticoagulants referred for the investigations of haematuria
|
Awan, M.T.
|
|
|
|
S3 |
p. S356
|
artikel
|
| 51 |
Concomitant immuno-radiotherapy in metastatic renal cell carcinoma: multicenter analysis
|
Francolini, G.
|
|
|
|
S3 |
p. S329-S330
|
artikel
|
| 52 |
Contemporary surgical and functional outcomes of anterolateral thigh flap for penile reconstruction
|
Lee, W.G.
|
|
|
|
S3 |
p. S243
|
artikel
|
| 53 |
Coping strategies and psychophysiological stress response of newly-diagnosed prostate cancer patients
|
Melgarejo Segura, M.T.
|
|
|
|
S3 |
p. S223
|
artikel
|
| 54 |
Correlation between Gleason score and PIRADS score on mpMRI –initial experience
|
Parameswaran, M.
|
|
|
|
S3 |
p. S101-S102
|
artikel
|
| 55 |
Could the therapeutic response in patients with non-muscle invasive bladder cancer be affected by chronic urinary retention?
|
Di Gianfrancesco, L.
|
|
|
|
S3 |
p. S228
|
artikel
|
| 56 |
Cribriform and intraductal carcinoma do not improve the nomogram-based selection of prostate cancer patients for pelvic lymph node dissection
|
De Barros, H.A.
|
|
|
|
S3 |
p. S240-S241
|
artikel
|
| 57 |
Cutaneous ureterostomy or ileal conduit urinary diversion: Can we spare the bowel following radical cystectomy in patients with solitary functioning kidney?
|
Nayak, B.
|
|
|
|
S3 |
p. S213
|
artikel
|
| 58 |
Defining the role of bilateral groin dissection for squamous cell carcinoma of the penis in South Africa
|
Jermy, S.B.
|
|
|
|
S3 |
p. S205
|
artikel
|
| 59 |
Definitive chemoradiotherapy with or without induction chemotherapy in patients with muscle invasive bladder cancer: Retrospective study
|
Mohamad, Y.M.M.M.
|
|
|
|
S3 |
p. S372
|
artikel
|
| 60 |
Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection
|
Meijer, D.
|
|
|
|
S3 |
p. S87
|
artikel
|
| 61 |
Developing a predictive model for additional lymph node metastases at inguinal lymph node dissection following positive sentinel node biopsy for penile cancer: An European multicentre evaluation
|
De Vries, H.M.
|
|
|
|
S3 |
p. S207
|
artikel
|
| 62 |
Development and evaluation of a real-world data-based prognostic score in castration-resistant metastatic prostate cancer
|
Gramaça, J.
|
|
|
|
S3 |
p. S302-S303
|
artikel
|
| 63 |
Development and validation of a molecular subtype-associated immune prognostic signature for muscle invasive bladder cancer
|
Zheng, Z.
|
|
|
|
S3 |
p. S200
|
artikel
|
| 64 |
Development of a predictive model for optimizing the selection of patients for second transurethral resection bladder (TURB)
|
Aragón Chamizo, J.
|
|
|
|
S3 |
p. S357-S358
|
artikel
|
| 65 |
Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
|
Maffei, D.
|
|
|
|
S3 |
p. S125
|
artikel
|
| 66 |
Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI- fusion biopsie
|
Maffei, D.
|
|
|
|
S3 |
p. S95-S96
|
artikel
|
| 67 |
Dilatation of short anterior urethral strictures with Optilume balloon: Initial experience in our centre
|
García Formoso, N.
|
|
|
|
S3 |
p. S267
|
artikel
|
| 68 |
Do all patients with suspicious prostate cancer need multiparametric magnetic resonance imaging before prostate biopsy?
|
Sousa Passos, P.
|
|
|
|
S3 |
p. S100
|
artikel
|
| 69 |
Docetaxel plus androgen deprivation therapy in older versus younger patients with metastatic hormone-sensitive prostate cancer: Real-world data
|
Monteiro, A.R.
|
|
|
|
S3 |
p. S146
|
artikel
|
| 70 |
Docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer: a real-life analysis
|
Tsaur, I.
|
|
|
|
S3 |
p. S283-S284
|
artikel
|
| 71 |
Does the intravesical administration of checkpoint inhibitors deserve consideration in non-muscle invasive bladder cancer?
|
Di Gianfrancesco, L.
|
|
|
|
S3 |
p. S209
|
artikel
|
| 72 |
Dosimetric and clinical results of the toxicity of image-guided radiotherapy for high-risk prostate cancer in western Algeria
|
Mous, A.
|
|
|
|
S3 |
p. S270
|
artikel
|
| 73 |
Dosimetric parameters in radiation treatment of prostate cancer: VMAT vs. 3DCRT
|
Camacho Fuentes, C.
|
|
|
|
S3 |
p. S268-S269
|
artikel
|
| 74 |
3D virtual and printed reconstructions of renal cell cancer with venous thrombus extension for surgical planning. Phase III NCT03738488
|
Rivero Belenchón, I.
|
|
|
|
S3 |
p. S313-S314
|
artikel
|
| 75 |
Earlier detection of recurrences using serum micro-RNA371 during active surveillance in men with stage I testicular germ cell tumours
|
Fankhauser, C.D.
|
|
|
|
S3 |
p. S345
|
artikel
|
| 76 |
Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719)
|
Francolini, G.
|
|
|
|
S3 |
p. S150
|
artikel
|
| 77 |
Editorial Board
|
|
|
|
|
S3 |
p. i-ii
|
artikel
|
| 78 |
Editorial Board
|
|
|
|
|
S3 |
p. i-ii
|
artikel
|
| 79 |
Editorial Board
|
|
|
|
|
S3 |
p. i-ii
|
artikel
|
| 80 |
Effectiveness of docetaxel addition to androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in real world practice
|
Kwonoh, P.
|
|
|
|
S3 |
p. S282
|
artikel
|
| 81 |
Efficacy and safety of Mitomycin chemohyperthermia vs. BCG for recurrence of bladder cancer during or after intravesical BCG: Single center experience
|
Kapogiannis, F.
|
|
|
|
S3 |
p. S377-S378
|
artikel
|
| 82 |
Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis
|
Quhal, F.
|
|
|
|
S3 |
p. S214-S215
|
artikel
|
| 83 |
Elderly patients (pts) with advanced Renal Cell Carcinoma (aRCC) treated with Nivolumab (N): A subgroup analysis from the WITNESS real-world study in France
|
Barthélémy, P.
|
|
|
|
S3 |
p. S182
|
artikel
|
| 84 |
Erectile dysfunction in young people with type I diabetes: Prevalence, comorbidities and therapeutic response
|
Oliveira, B.
|
|
|
|
S3 |
p. S262
|
artikel
|
| 85 |
Estrogen receptor alpha (ERα) expression in prostate cancer (PCa) epithelium and stroma
|
Puchinskaya, M.
|
|
|
|
S3 |
p. S245
|
artikel
|
| 86 |
Evaluating confocal laser microscopy to assess intraoperative surgical margin status of prostatectomy specimen, a feasibility study (ENCLOSURE-1)
|
Baas, D.J.H.
|
|
|
|
S3 |
p. S259
|
artikel
|
| 87 |
Evaluation of adjuvant targeted therapy for local reccurence of renal cell carcinoma after radical nephrectomy
|
Tlili, G.
|
|
|
|
S3 |
p. S317-S318
|
artikel
|
| 88 |
Evaluation of preoperative biopsy, prognostic factors and oncologic outcome in upper tract urothelial carcinoma (UTUC)
|
Koll, F.J.
|
|
|
|
S3 |
p. S369
|
artikel
|
| 89 |
Evaluation of the impact of adjuvant versus salvage radiotherapy in the recurrence-free survival in post-radical prostatectomy patients with positive surgical margins
|
Macedo Alves Peyroteo Gomes, I.
|
|
|
|
S3 |
p. S116
|
artikel
|
| 90 |
Excision and primary anastomosis or staged urethroplasty for anastomotic strictures after phalloplasty?
|
Waterschoot, M.
|
|
|
|
S3 |
p. S261
|
artikel
|
| 91 |
Exploratory analyses of incidence of skin rash and efficacy with apalutamide (APA) treatment of patients (pts) with advanced prostate cancer in SPARTAN and TITAN studies
|
Azad, A.A.
|
|
|
|
S3 |
p. S286-S287
|
artikel
|
| 92 |
Expression analysis and mutational status of histone methyltransferase KMT2D at different upper tract urothelial carcinoma locations
|
Laukhtina, E.
|
|
|
|
S3 |
p. S352
|
artikel
|
| 93 |
Extended robot-assisted laparoscopic prostatectomy and extended pelvic lymph node dissection as a monotherapy for very high-risk prostate cancer patients
|
Miura, N.
|
|
|
|
S3 |
p. S267
|
artikel
|
| 94 |
Extended - targeted-plus-regional - MRI-directed biopsy approach in prostate cancer diagnosis – a systematic review and meta-analysis
|
Hagens, M.J.
|
|
|
|
S3 |
p. S242-S243
|
artikel
|
| 95 |
External validation and addition of PSMA-PET to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: An international multicenter study
|
Meijer, D.
|
|
|
|
S3 |
p. S191-S193
|
artikel
|
| 96 |
External validation of biochemical definition to predict oncologic outcomes following focal therapy for localized prostate cancer using high intensity focused ultrasound
|
Mattlet, A.
|
|
|
|
S3 |
p. S260
|
artikel
|
| 97 |
External validation of the Rotterdam Prostate Cancer Risk Calculator and the Prostate Biopsy Collaborative Group Risk Calculator in a Swedish population-based screening cohort
|
Chandra Engel, J.
|
|
|
|
S3 |
p. S216-S217
|
artikel
|
| 98 |
External validation of the Soeterik nomogram for side-specific extraprostatic extension after robot-assisted radical prostatectomy
|
Veerman, H.
|
|
|
|
S3 |
p. S224-S225
|
artikel
|
| 99 |
External validation of the SPARE nephrometric index as a predictor of early complications after partial nephrectomy
|
Santiago Gonzalez, M.
|
|
|
|
S3 |
p. S322-S323
|
artikel
|
| 100 |
Extracorporeal nephron-sparing surgery with kidney autotransplantation for complex renal cell carcinoma
|
Lesovoy, V.
|
|
|
|
S3 |
p. S196
|
artikel
|
| 101 |
Factors influencing physician prescribing for muscle-invasive urothelial carcinoma in Europe
|
Broughton, E.
|
|
|
|
S3 |
p. S393
|
artikel
|
| 102 |
Factors influencing survival after stage I Renal Cell Carcinoma (RCC) progression
|
Puchinskaya, M.
|
|
|
|
S3 |
p. S337
|
artikel
|
| 103 |
Features and survival outcome of patients with relapsed germ cell tumors
|
Blanco Abad, C.
|
|
|
|
S3 |
p. S240-S241
|
artikel
|
| 104 |
Features of molecular profile of prostate cancer after neoadjuvant treatment
|
Berkut, M.
|
|
|
|
S3 |
p. S174
|
artikel
|
| 105 |
Female urethroplasty for the treatment of urethral stricture, which surgical option to choose? About two cases: oral mucosal graft and vaginal mucosal flap
|
Barrera, C.
|
|
|
|
S3 |
p. S264
|
artikel
|
| 106 |
Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma
|
Kardoust Parizi, M.
|
|
|
|
S3 |
p. S403
|
artikel
|
| 107 |
First-in-man: neurovascular-sparing magnetic resonance-guided adaptive radiotherapy for localized prostate cancer for preservation of erectile function
|
Teunissen, F.R.
|
|
|
|
S3 |
p. S251-S252
|
artikel
|
| 108 |
Free-hand transperineal prostate biopsy with MRI-fusion in an outpatient setting: experience in brazil
|
Teixeira Dias, A.E.
|
|
|
|
S3 |
p. S239
|
artikel
|
| 109 |
Functional outcomes of glansectomy and reconstruction with split-thickness skin graft
|
Murányi, M.
|
|
|
|
S3 |
p. S242
|
artikel
|
| 110 |
Fusion verses cognitive MRI-guided prostate biopsies in diagnosing clinically significant prostate cancer
|
Lockhart, K.
|
|
|
|
S3 |
p. S215
|
artikel
|
| 111 |
68Ga PSMA PET/CT for staging high risk prostate cancer patients suitable for radical treatments: Effective clinic implication and preliminary diagnostic performance
|
Bianchi, L.
|
|
|
|
S3 |
p. S218
|
artikel
|
| 112 |
68Ga-PSMA-PET/CT in newly diagnosed patients on active surveillance (PASPoRT study)
|
Heetman, J.G.
|
|
|
|
S3 |
p. S212
|
artikel
|
| 113 |
Gastrointestinal and genitourinary late toxicity after radical chemo-radiotherapy in patients with invasive bladder cancinoma
|
Soulimioti, G.
|
|
|
|
S3 |
p. S382
|
artikel
|
| 114 |
Geriatric assessment tools and preliminary patient-reported outcomes in a cohort of elderly patients treated with 1.5T MR-guided and daily adapted abdominal-pelvic SBRT
|
Mazzola, R.
|
|
|
|
S3 |
p. S153
|
artikel
|
| 115 |
Germ cell tumors with malignant somatic transformation: Genomic profile by FoundationOne CDx test
|
Scavuzzo, A.
|
|
|
|
S3 |
p. S342-S344
|
artikel
|
| 116 |
Germline genetic testing in prostate cancer: An evaluation for all?
|
Bilé Silva, A.
|
|
|
|
S3 |
p. S214
|
artikel
|
| 117 |
Germline genetic testing in prostate cancer: Practical implications of NCCN guidelines
|
Bilé Silva, A.
|
|
|
|
S3 |
p. S213
|
artikel
|
| 118 |
Glycosaminoglycan (GAG) scores for surveillance of recurrence in Leibovich Points ≥5 non-metastatic clear cell renal cell carcinoma: AURORAX-0087A trial in progress report
|
Dabestani, S.
|
|
|
|
S3 |
p. S206-S207
|
artikel
|
| 119 |
Going transperineal: In-office freehand transperineal prostate biopsies outcomes
|
Bilé Silva, A.
|
|
|
|
S3 |
p. S227
|
artikel
|
| 120 |
Head-to-head comparison of high resolution micro-ultrasound and multiparametric magnetic resonance imaging for detecting extraprostatic extension in prostate cancer
|
Paciotti, M.
|
|
|
|
S3 |
p. S264
|
artikel
|
| 121 |
Head-to-head comparison of prostate cancer detection rate at MRI-targeted FUSION biopsy between hub and spoke mpMRI Italian centers
|
Bianchi, L.
|
|
|
|
S3 |
p. S236
|
artikel
|
| 122 |
Health-Related Quality of Life (HRQoL) in men with metastatic Castration-Resistant Prostate Cancer (mCRPC) receiving Talazoparib (TALA): TALAPRO-1
|
Stenzl, A.
|
|
|
|
S3 |
p. S198-S199
|
artikel
|
| 123 |
Hereditary prostate cancer screening
|
Sultanbaev, A.
|
|
|
|
S3 |
p. S155
|
artikel
|
| 124 |
Histologic variants of urothelial carcinoma: does it change the survival outcomes in patients with bladder cancer managed with radical cystectomy?
|
Dos Santos Reis Pereira, J.N.
|
|
|
|
S3 |
p. S375
|
artikel
|
| 125 |
How can we reduce the rate of incomplete resection in patients with non-muscle-invasive bladder cancer (NMIBC) undergoing first transurethral resection of bladder tumor (TURBT)? Impact of two-loop wide resection of surrounding tumor tissue
|
Yanagi, M.
|
|
|
|
S3 |
p. S379-S380
|
artikel
|
| 126 |
How often is Cloquet’s node involved in prostate cancer lymph node metastasis?
|
Rivero Belenchón, I.
|
|
|
|
S3 |
p. S98
|
artikel
|
| 127 |
Hybrid ICG-99mTc-nanocolloid, on the road towards becoming the new standard for sentinel node biopsy in penile cancer?
|
De Vries, H-M.
|
|
|
|
S3 |
p. S94
|
artikel
|
| 128 |
Identification of determinants influencing quality of life in metastatic prostate cancer patients
|
Tlili, G.
|
|
|
|
S3 |
p. S304-S305
|
artikel
|
| 129 |
Identifying the most appropriate instrument for Patient-Reported Outcome Measures (PROMs) in patients with clinically localised prostate cancer
|
Ratti, M.M.
|
|
|
|
S3 |
p. S132-S133
|
artikel
|
| 130 |
Idiopathic cavernosal abscess with urethral stricture
|
Oliveira, B.
|
|
|
|
S3 |
p. S254-S255
|
artikel
|
| 131 |
Immunotherapy in metastatic urothelial cell carcinoma: survival and safety long-term results
|
Ruíz Guerrero, E.
|
|
|
|
S3 |
p. S381
|
artikel
|
| 132 |
Impact of nephrectomy on clinical outcomes and feasibility of radiation therapy in patients (pts) with advanced Renal Cell Carcinoma (aRCC) treated with nivolumab: Subgroup analyses from the WITNESS real-world study in France
|
Albiges, L.
|
|
|
|
S3 |
p. S321
|
artikel
|
| 133 |
Impact of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) use on the efficacy and safety of immune Checkpoint Inhibitors (CPI) in patients with advanced Renal Cell Carcinoma (RCC) and Urothelial Carcinoma (UC): A retrospective multicenter analysis
|
Martinez Chanza, N.
|
|
|
|
S3 |
p. S193-S194
|
artikel
|
| 134 |
Impact of race on outcomes among BCG-treated high-risk non-muscle invasive bladder cancer patients in an equal access setting
|
Lawler, C.
|
|
|
|
S3 |
p. S364
|
artikel
|
| 135 |
Impact of the COVID-19 pandemic on the surgical waiting time in urological prosthetic surgery in a tertiary hospital
|
García Formoso, N.
|
|
|
|
S3 |
p. S249
|
artikel
|
| 136 |
Impact of the metabolic syndrome on the renal function after partial nephrectomy for non metastatic localized renal cell carcinoma
|
Chaker, K.
|
|
|
|
S3 |
p. S335
|
artikel
|
| 137 |
Impact on survival outcomes of poorly controlled hypertension after initiation of abiraterone/enzalutamide in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC)
|
Pozas, J.
|
|
|
|
S3 |
p. S301
|
artikel
|
| 138 |
Incidence of brain metastases in high risk renal cell carcinoma – a single centre study. Should we routinely be including CT brains as part of surveillance?
|
Smith, P.
|
|
|
|
S3 |
p. S205
|
artikel
|
| 139 |
Initial steps of an online search tool development for diagnostic and prognostic factors in prostate cancer
|
Beyer, K.
|
|
|
|
S3 |
p. S175-S176
|
artikel
|
| 140 |
Inter-laboratory variation in Gleason grading influences treatment choice: a Dutch historic cohort study in 30,509 prostate cancer patients
|
Flach, R.N.
|
|
|
|
S3 |
p. S237-S238
|
artikel
|
| 141 |
Intraoperative endoscopic assistance in posterior urethral surgeries
|
Campos Juanatey, F.
|
|
|
|
S3 |
p. S271
|
artikel
|
| 142 |
Intravesical bacillus Calmette - Guérin (BCG) in treating non-muscle invasive bladder cancer (NMIBC)- Analysis of adverse effects and effectiveness between two strains of BCG (Danish 1331 and Moscow)
|
Agarwal, V.
|
|
|
|
S3 |
p. S223
|
artikel
|
| 143 |
IO-Synthesise RCC: A pooled analysis of real-world outcomes for advanced renal cell carcinoma patients treated with nivolumab in France and Germany
|
Thiery-Vuillemin, A.
|
|
|
|
S3 |
p. S180-S181
|
artikel
|
| 144 |
IO-Synthesise RCC: Real-world outcomes with nivolumab in previously treated advanced renal cell carcinoma, a pooled analysis of patients from France and Germany
|
Grimm, M-O.
|
|
|
|
S3 |
p. S319-S320
|
artikel
|
| 145 |
Is a course of Intermittent Self-Dilatation (ISD) with topical corticosteroids superior at stabilising urethral stricture disease in men and improving functional outcomes over a course of ISD alone? A systematic review and meta-analysis
|
Verla, W.
|
|
|
|
S3 |
p. S240
|
artikel
|
| 146 |
Is fosfomycin really trustworthy as antibiotic prophylaxis in transrectal prostate biopsy? A prospective study
|
Cardoso, A.
|
|
|
|
S3 |
p. S232
|
artikel
|
| 147 |
Is prostate cancer diagnosis affected by biopsy needle length? A prospective study
|
Cardoso, A.
|
|
|
|
S3 |
p. S233-S234
|
artikel
|
| 148 |
Is the percentage of teratoma in the orchiectomy specimen predictive of teratoma in retroperitoneal residual masses after chemotherapy in nonseminomatous germ cell tumors?
|
Boussaffa, H.
|
|
|
|
S3 |
p. S242
|
artikel
|
| 149 |
Is transurethral resection alone accurate enough for the diagnosis of variant histology bladder cancer compared with radical cystectomy? A 12-year retrospective study
|
Fernandes, M.
|
|
|
|
S3 |
p. S360
|
artikel
|
| 150 |
Linac-based SBRT for local recurrent prostate cancer after previous radiotherapy
|
Cuccia, F.
|
|
|
|
S3 |
p. S139
|
artikel
|
| 151 |
Local features of penetrant mutations incidence in patients with prostate cancer in Republic of Bashkortostan
|
Sultanbaev, A.
|
|
|
|
S3 |
p. S263
|
artikel
|
| 152 |
Long term experience of treatment of renal tumours with cryotherapy. Follow-up with CT and contrast-enhanced ultrasound
|
Santiago Gonzalez, M.
|
|
|
|
S3 |
p. S315-S316
|
artikel
|
| 153 |
Long-term follow up for non-muscle invasive bladder cancer: Do cancer care protocol remain effective few years post implementation?
|
Raysee, A.
|
|
|
|
S3 |
p. S404
|
artikel
|
| 154 |
Long-term functional results of orthotopic urinary derivation by Studer and VIP after radical cystectomy in women
|
Atduev, V.
|
|
|
|
S3 |
p. S368
|
artikel
|
| 155 |
Magnetic resonance Imaging-based radiomics signature for preoperative prediction of Ki67 expression and outcome in bladder cancer
|
Zheng, Z.
|
|
|
|
S3 |
p. S407
|
artikel
|
| 156 |
Management and survival of patients with retroperitoneal recurrences following radical nephrectomy: Results from a multi-institutional international datasets
|
Marchioni, M.
|
|
|
|
S3 |
p. S90
|
artikel
|
| 157 |
Management of metastatic prostate cancer in older patients
|
Mata Alcaraz, M.
|
|
|
|
S3 |
p. S299-S300
|
artikel
|
| 158 |
Management of stage I testicular germ cell tumours – the experience of a comprehensive cancer centre in Portugal
|
Vaz-Ferreira, A.
|
|
|
|
S3 |
p. S348
|
artikel
|
| 159 |
McAninch penile circular skin flap urethroplasty: Do skin flaps still have a role in complex urethral strictures?
|
Miranda, M.
|
|
|
|
S3 |
p. S272
|
artikel
|
| 160 |
Metabolic-associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer
|
Zheng, Z.
|
|
|
|
S3 |
p. S349
|
artikel
|
| 161 |
Metastasis-directed Stereotactic Body Radiotherapy (SBRT)-guided by pet-ct 18f-choline versus pet-ct 68ga-psma in castration sensitive oligorecurrent prostate cancer: A comparative effectiveness analysis
|
Mazzola, R.
|
|
|
|
S3 |
p. S140
|
artikel
|
| 162 |
Metastasis-free survival after salvage radiotherapy for post-operative prostate cancer patients in the PSMA PET/CT era – a multicenter analysis
|
Zamboglou, C.
|
|
|
|
S3 |
p. S261-S262
|
artikel
|
| 163 |
Metastatic renal-cell carcinoma – Differences between 1 or 2 prognostic factors – Real World Data
|
Sousa, M.J.
|
|
|
|
S3 |
p. S328
|
artikel
|
| 164 |
Micropapillary bladder cancer: A clinicopathologic characterization and treatment analysis
|
Saadi, A.
|
|
|
|
S3 |
p. S238-S239
|
artikel
|
| 165 |
Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
|
Maffei, D.
|
|
|
|
S3 |
p. S105
|
artikel
|
| 166 |
Molecular subtypes of fully resected clear cell renal cell carcinoma are prognostic for risk of relapse and may impact adjuvant treatment
|
Roussel, E.
|
|
|
|
S3 |
p. S91
|
artikel
|
| 167 |
Multicentre evaluation of multidisciplinary teams functioning on advanced prostate cancer
|
Belda Ferre, M.
|
|
|
|
S3 |
p. S297-S298
|
artikel
|
| 168 |
Multiparametric MRI-based radiomics signature for preoperative estimation of basal and luminal features in bladder cancer
|
Zheng, Z.
|
|
|
|
S3 |
p. S408
|
artikel
|
| 169 |
Near infrared light in prostate cancer diagnosis
|
Khuskivadze, A.
|
|
|
|
S3 |
p. S97
|
artikel
|
| 170 |
Neoadjuvant chemotherapy in patients with urothelial bladder cancer
|
Catarino, R.
|
|
|
|
S3 |
p. S414
|
artikel
|
| 171 |
Neoadjuvant docetaxel treatment for locally advanced prostate cancer: A clinicopathologic study
|
Berkut, M.
|
|
|
|
S3 |
p. S141
|
artikel
|
| 172 |
Nerve-sparing radical prostatectomy in obese patients
|
Sokolov, E.
|
|
|
|
S3 |
p. S106-S107
|
artikel
|
| 173 |
Neutrophil-to-lymphocyte ratio as biomarker for predicting locally advanced disease and survival in patients treated with radical cystectomy
|
Pinheiro, A.M.
|
|
|
|
S3 |
p. S230
|
artikel
|
| 174 |
Non-standard treatment and quality of life for testicular cancer survivors
|
Boussaffa, H.
|
|
|
|
S3 |
p. S244
|
artikel
|
| 175 |
Occupational and environmental risk factors for prostate cancer: Case-control study with literature review
|
Tlili, G.
|
|
|
|
S3 |
p. S208-S209
|
artikel
|
| 176 |
Oncological outcomes following radical cystectomy in elderly patients
|
Artiles Medina, A.
|
|
|
|
S3 |
p. S224-S226
|
artikel
|
| 177 |
Oncological results of laser fulguration versus transurethral resection in bladder tumors
|
Mazuecos Quiros, J.
|
|
|
|
S3 |
p. S210-S212
|
artikel
|
| 178 |
Oncologic results of radical prostatectomy for high-risk prostate cancer and prognostic factors for recurrence and progression-free survival
|
Zaghbib, S.
|
|
|
|
S3 |
p. S152
|
artikel
|
| 179 |
One-stage anterior urethroplasty with nanofat grafting: Preliminary results in our referral center
|
Berdondini, E.
|
|
|
|
S3 |
p. S266
|
artikel
|
| 180 |
Optimal Chemotherapy for Cisplatin-Ineligible Advanced URothelial Cancer: Gemcitabine with CArboplatin vs. Paclitaxel-Prospective Randomized Trial (CAUR CAP TRIAL)
|
Kumar, P.
|
|
|
|
S3 |
p. S392
|
artikel
|
| 181 |
Oral mucosa grafting for reconstruction of severe vulvar stenosis due to lichen sclerosus
|
Campos Juanatey, F.
|
|
|
|
S3 |
p. S270
|
artikel
|
| 182 |
Outcomes comparison between standard monopolar coagulation and PlasmaJet™ surgical device in open off-clamp sutureless partial nephrectomy for pT1a renal tumors
|
Kapogiannis, F.
|
|
|
|
S3 |
p. S183-S184
|
artikel
|
| 183 |
Outcomes eight years later Image guided radiotherapy with fiducials in low and intermediate prostate cancer
|
Salas Buzón, M.C.
|
|
|
|
S3 |
p. S257
|
artikel
|
| 184 |
Outcomes of multiple partial nephrectomy for multifocal renal masses
|
Picola Brau, N.
|
|
|
|
S3 |
p. S187
|
artikel
|
| 185 |
Overall survival of patients receiving cisplatin or carboplatin for primary metastatic urothelial carcinoma of the bladder: A contemporary Dutch nationwide cohort study
|
Richters, A.
|
|
|
|
S3 |
p. S391
|
artikel
|
| 186 |
Pancreatic and thyroid metastases from Renal Cell Carcinoma (RCC): A single center 10-year experience
|
Puchinskaya, M.
|
|
|
|
S3 |
p. S204
|
artikel
|
| 187 |
Patient preferences for adjuvant treatment in muscle-invasive urothelial carcinoma: A multi-country discrete choice experiment
|
Broughton, E.
|
|
|
|
S3 |
p. S374
|
artikel
|
| 188 |
Patient-reported pain by baseline pain status in men with metastatic Castration-Resistant Prostate Cancer (mCRPC) receiving Talazoparib (TALA): TALAPRO-1
|
Stenzl, A.
|
|
|
|
S3 |
p. S308-S309
|
artikel
|
| 189 |
Patient-reported pain by clinical outcome in men with metastatic Castration-Resistant Prostate Cancer (mCRPC) receiving Talazoparib (TALA): TALAPRO-1
|
Stenzl, A.
|
|
|
|
S3 |
p. S306-S307
|
artikel
|
| 190 |
Patient-specific magnetic resonance imaging-based 3D models may lower the positive surgical margin rate at robot-assisted radical prostatectomy
|
Veerman, H.
|
|
|
|
S3 |
p. S254-S255
|
artikel
|
| 191 |
PD-L1 expression in renal cell carcinoma with rhabdoid/sarcomatoid features
|
Rodrigues Fonseca, R.
|
|
|
|
S3 |
p. S312
|
artikel
|
| 192 |
Penoscrotal decompression: A new paradigm for managing prolonged ischemic priapism
|
Lee, W.G.
|
|
|
|
S3 |
p. S246
|
artikel
|
| 193 |
Penoscrotal “M” reconstruction for large penile cancer
|
Vieira E Brito, D.
|
|
|
|
S3 |
p. S239
|
artikel
|
| 194 |
Percentage change in tumour size after three months of the treatment and trough level of axitinib in second line renal cell carcinoma patients
|
Synowiec, Z.
|
|
|
|
S3 |
p. S332
|
artikel
|
| 195 |
Percutaneous tumor ablation compared to partial nephrectomy for cT1a renal cancer: the impact of histologic variant
|
Bianchi, L.
|
|
|
|
S3 |
p. S327
|
artikel
|
| 196 |
Perioperative pembrolizumab or pembrolizumab + enfortumab vedotin and cystectomy versus cystectomy alone in cisplatin-ineligible patients with muscle-invasive bladder cancer: Phase 3 KEYNOTE-905/EV-303 study
|
Necchi, A.
|
|
|
|
S3 |
p. S394
|
artikel
|
| 197 |
Peyronie’s disease: Differences in male and female personal experience
|
Mendes Andrade, V.
|
|
|
|
S3 |
p. S248
|
artikel
|
| 198 |
PIONEER consensus on clinician reported outcome measurements
|
Beyer, K.
|
|
|
|
S3 |
p. S156-S159
|
artikel
|
| 199 |
PIONEER’s operational definitions: Harmonising clinical characteristics and phenotypes data of prostate cancer patients
|
Beyer, K.
|
|
|
|
S3 |
p. S160-S161
|
artikel
|
| 200 |
Poorly differentiated urothelial carcinoma of the bladder and the impact of plasmacytoid variant
|
Lockhart, K.
|
|
|
|
S3 |
p. S399-S400
|
artikel
|
| 201 |
Post-urethroplasty fistula closure with PATIO technique: An alternative for the repair of urethro-cutaneous fistulas
|
Cámara Moreno, C.
|
|
|
|
S3 |
p. S252-S253
|
artikel
|
| 202 |
Post-Urethroplasty fistula, review of our series
|
Cámara Moreno, C.
|
|
|
|
S3 |
p. S251
|
artikel
|
| 203 |
Predicting out bore prostate cancer focal laser ablation failure and biochemical relapse using the correlation with the surrounding tissue temperature parameters during treatment
|
Mertziotis, N.
|
|
|
|
S3 |
p. S114-S115
|
artikel
|
| 204 |
Predictive factors of tumor recurrence and progression in high-risk non-muscle-invasive bladder cancer
|
Mahjoubi, Z.
|
|
|
|
S3 |
p. S229
|
artikel
|
| 205 |
Predictive models for diagnosing prostate cancer using the PI-RADSv2 classification and the PSA density
|
Rodríguez Cabello, M.A.
|
|
|
|
S3 |
p. S231
|
artikel
|
| 206 |
Predictors of complete response to neoadjuvant chemotherapy in non-metastatic bladder cancer
|
Sousa Passos, P.
|
|
|
|
S3 |
p. S218
|
artikel
|
| 207 |
Predictors of intravesical recurrence after radical nephroureterectomy and prognosis in patients with upper tract urothelial carcinoma
|
Ouanes, Y.
|
|
|
|
S3 |
p. S409-S411
|
artikel
|
| 208 |
Predictors of residual disease in restaging transurethral resection for high-risk non-muscle invasive bladder cancer
|
Gonçalves Correia, J.R.
|
|
|
|
S3 |
p. S395
|
artikel
|
| 209 |
Preferences and utility scores for the treatment of localized prostate cancer
|
Teunissen, F.R.
|
|
|
|
S3 |
p. S249-S250
|
artikel
|
| 210 |
Preliminary results of patient reported quality of life outcome from moderate and extreme hypo fractionation for localised prostatic adenocarcinoma
|
Basu, T.
|
|
|
|
S3 |
p. S129
|
artikel
|
| 211 |
Pre-operative Cardiopulmonary Exercise Testing (CPET) assessment in radical cystectomy
|
Lockhart, K.
|
|
|
|
S3 |
p. S361-S362
|
artikel
|
| 212 |
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for non-metastatic urothelial carcinoma of the bladder
|
Laukhtina, E.
|
|
|
|
S3 |
p. S412
|
artikel
|
| 213 |
Prognostic and predictive value of total tumor burden particularly on pulmonary localization in patients with clear-cell Renal Cell Carcinoma (mRCC) subjected to molecular-targeted therapy
|
Buraczewska, A.
|
|
|
|
S3 |
p. S192
|
artikel
|
| 214 |
Prognostic impact of serum C-reactive protein in metastatic clear-cell renal cell carcinoma patients treated with nivolumab
|
Roussel, E.
|
|
|
|
S3 |
p. S198
|
artikel
|
| 215 |
Prognostic value of the clonal origin of lymph node metastases in prostate cancer
|
De Barros, H.A.
|
|
|
|
S3 |
p. S271-S272
|
artikel
|
| 216 |
Prognostic value of tPSA’s early response in elderly patients with metastatic castration-resistant prostate cancer in treatment with Enzalutamide
|
Costa, I.
|
|
|
|
S3 |
p. S149
|
artikel
|
| 217 |
Prospective analysis of prostate cancer local staging with [18F]PSMA PET/MRI combined with multiparametric MRI – A comparison to histopathology in the radical prostatectomy specimen. – ProStaPET –
|
Bodar, Y.J.L.
|
|
|
|
S3 |
p. S220-S222
|
artikel
|
| 218 |
Prospective multicentre analysis of oral morbidity after harvesting oral mucosa grafts for urethroplasties
|
Calleja Hermosa, P.
|
|
|
|
S3 |
p. S247
|
artikel
|
| 219 |
Prostate biopsies by micro-ultrasound for clinically significant cancer detection: Results from a high-volume center
|
Maffei, D.
|
|
|
|
S3 |
p. S226
|
artikel
|
| 220 |
Prostate cancer in men older 70 years with severe hypofractionation radiotherapy
|
Salas Buzón, M.C.
|
|
|
|
S3 |
p. S112
|
artikel
|
| 221 |
Prostate cancer risk calculators – PBCG vs. PCPT 2.0: Which one should we use when it comes to clinical decision-making?
|
Silva, A.B.
|
|
|
|
S3 |
p. S170
|
artikel
|
| 222 |
Prostate cancer risk stratification based on a novel mathematical model developed by combining multiple clinical, biochemical and prostate imaging diagnostic parameters
|
Spyropoulos, E.
|
|
|
|
S3 |
p. S99
|
artikel
|
| 223 |
Prostate stereotactic radiotherapy: Efficacy and toxicity profile with the use of endorectal ballon
|
Laranja, C.
|
|
|
|
S3 |
p. S111
|
artikel
|
| 224 |
Proximity to oil refineries and risk of bladder cancer: A population-based analysis
|
Williams, S.
|
|
|
|
S3 |
p. S208
|
artikel
|
| 225 |
PSA as a prognostic factor at 7 months of anti-androgenic therapy and docetaxel
|
Basto, R.
|
|
|
|
S3 |
p. S295
|
artikel
|
| 226 |
PSA changes after laser ablation of prostate cancer and its relation with the extent of the thermal damage on the malignant tissue
|
Mertziotis, N.
|
|
|
|
S3 |
p. S164-S165
|
artikel
|
| 227 |
PSMA-PET- and mpMRI-guided focal radiation dose escalation in primary prostate cancer patients – a planned safety analysis of a two-armed prospective phase II trial (HypoFocal)
|
Spohn, S.K.B.
|
|
|
|
S3 |
p. S210
|
artikel
|
| 228 |
Quality of life of patients with hormone-dependent advanced prostate cancer receiving palliative treatment with Leuprorelin depot injection (Lutrate®) – interim results from a non-interventional study in Germany
|
Geiges, G.
|
|
|
|
S3 |
p. S144
|
artikel
|
| 229 |
Quantifying resection quality in radical prostatectomy through histopathologic scoring of positive surgical margins
|
Keller, R.F.M.S.
|
|
|
|
S3 |
p. S108-S109
|
artikel
|
| 230 |
Radiation proctitis in prostate cancer treated by external beam radiotherapy: A 10-year retrospective study
|
Pereira, K.
|
|
|
|
S3 |
p. S124
|
artikel
|
| 231 |
Radiotherapy with or without chemotherapy in muscle invasive bladder cancer – a retrospective, single institution review of outcomes
|
Mehta, A.
|
|
|
|
S3 |
p. S387-S388
|
artikel
|
| 232 |
Radium 223 in metastatic castration resistant prostate prostate. Effectiveness in clinical practice
|
Salas Buzón, M.C.
|
|
|
|
S3 |
p. S148
|
artikel
|
| 233 |
Rare histological variants of bladder cancer: TURBT and radical cystectomy concordance predictors
|
Tappero, S.
|
|
|
|
S3 |
p. S359
|
artikel
|
| 234 |
Real-life data of Atezolizumab in urothelial carcinoma, second-line metastatic disease
|
Sánchez-Cousido, L.F.
|
|
|
|
S3 |
p. S217
|
artikel
|
| 235 |
Real-life data of Cabazitaxel-Prednisone second-line scheme in metastatic castration-resistant prostate cancer
|
Sánchez-Cousido, L.F.
|
|
|
|
S3 |
p. S151
|
artikel
|
| 236 |
Real-life data of Nivolumab in second-line metastatic renal cell cancer
|
Sánchez-Cousido, L.F.
|
|
|
|
S3 |
p. S197
|
artikel
|
| 237 |
Real-world evidence for interobserver-agreement of PI-RADS-version-2 and the value of combining 4-core-targeted-MRI-TRUS-fusion and systematic-12-core-TRUS prostate biopsy for the diagnosis of prostate cancer according to biopsy-history
|
Mischinger, J.
|
|
|
|
S3 |
p. S244
|
artikel
|
| 238 |
Real-world survival analysis in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in Slovenia
|
Mencinger, M.
|
|
|
|
S3 |
p. S293
|
artikel
|
| 239 |
Renal trauma: A 5 year retrospective analysis of a level 1 trauma center in Portugal
|
Mendes Andrade, V.
|
|
|
|
S3 |
p. S236
|
artikel
|
| 240 |
Renal tumors with left renal vein tumoral thrombosis. Is Preoperative Renal Artery Embolization (PRAE) helpful?
|
Cano Velasco, J.
|
|
|
|
S3 |
p. S324-S326
|
artikel
|
| 241 |
Repair of long anterior urethral strictures combining a non-transecting anastomotic urethroplasty and an urethroplasty with buccal mucosal grafts in a dorso-lateral position using the Kulkarni technique
|
García Formoso, N.
|
|
|
|
S3 |
p. S273
|
artikel
|
| 242 |
Reproducibility of tumor staging depends on the applied PSMA-radiotracer - A retrospective analysis on the interobserver variability of PSMA-PET/CT
|
Hagens, M.J.
|
|
|
|
S3 |
p. S194-S197
|
artikel
|
| 243 |
Risk factors associated with bladder recurrence in upper urothelial tumor
|
Minguez Ojeda, C.
|
|
|
|
S3 |
p. S405-S406
|
artikel
|
| 244 |
Risk factors for inguinal lymph node metastases in men with T1G2 penile cancer: a multi centre collaborative study
|
Fankhauser, C.D.
|
|
|
|
S3 |
p. S206
|
artikel
|
| 245 |
Risk of second malignancies and survival differences by treatment pattern in prostate cancer: A population-based study
|
Giusti, F.
|
|
|
|
S3 |
p. S126
|
artikel
|
| 246 |
Robotic Assisted Laparoscopic Radical Nephrectomy (RALN) for T3a tumours with renal vein involvement
|
Jones, C.
|
|
|
|
S3 |
p. S189
|
artikel
|
| 247 |
Robotic assisted MRI-US fusion guided target saturation biopsy of the prostate – preliminary results for diagnostic accuracy and clinical implications
|
Wetterauer, C.
|
|
|
|
S3 |
p. S229
|
artikel
|
| 248 |
Salvage pelvic lymph node dissection in oligorecurrent prostate cancer – Which patients really benefit?
|
Gonçalves Correia, J.R.
|
|
|
|
S3 |
p. S277
|
artikel
|
| 249 |
Salvage radiotherapy as targeted treatment in oligorrecurrent patients with prostate cancer
|
González Calvo, E.
|
|
|
|
S3 |
p. S142
|
artikel
|
| 250 |
Salvage radiotherapy for prostate cancer on relapse after radical prostatectomy - How important is an early start?
|
Rodrigues, I.
|
|
|
|
S3 |
p. S110
|
artikel
|
| 251 |
SBRT in oligometastatic prostate cancer
|
Sánchez Cortés, C.
|
|
|
|
S3 |
p. S279-S280
|
artikel
|
| 252 |
Secondary buried penis reconstruction - Tricks to maintain the penile length in patients with already compromised scrotum and penis
|
Ameli, G.
|
|
|
|
S3 |
p. S263
|
artikel
|
| 253 |
Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in patients with pN+ bladder cancer
|
Afferi, L.
|
|
|
|
S3 |
p. S365-S367
|
artikel
|
| 254 |
Self-reported quality of life in metastatic renal cell carcinoma is related to oncological outcomes in real-world patients
|
Mazuecos Quiros, J.
|
|
|
|
S3 |
p. S199-S200
|
artikel
|
| 255 |
Semen exo-oncomiRNAs: A tool for prostate cancer aggressiveness diagnosis
|
Ruiz Plazas, X.
|
|
|
|
S3 |
p. S178
|
artikel
|
| 256 |
Sexual function in testicular cancer survivors
|
Ferreira, A.
|
|
|
|
S3 |
p. S346
|
artikel
|
| 257 |
Sexual function of men undergoing single prostate cancer treatment – results of the EUPROMS study
|
Venderbos, L.D.F.
|
|
|
|
S3 |
p. S130-S131
|
artikel
|
| 258 |
Should patients with active urological cancers receive thromboprophylaxis for Cancer Associated Thrombosis (CAT)?
|
Tsoukalas, N.G.
|
|
|
|
S3 |
p. S417-S418
|
artikel
|
| 259 |
Single center five-years results of AdVance/AdVance XP suburethral sling for post-prostatectomy incontinence
|
Barragan Flores, W.A.
|
|
|
|
S3 |
p. S237
|
artikel
|
| 260 |
Single-stage ventral onlay and tubular urethral reconstruction using penile preputial flap as an alternative to staged oral grafts approach for a complicated urethral stricture: A case report
|
Ameli, G.
|
|
|
|
S3 |
p. S234-S235
|
artikel
|
| 261 |
Staging with 2-[18F] FDG PET/CT in pediatric patients with testicular malignancies
|
Acuna Hernandez, M.
|
|
|
|
S3 |
p. S339-S340
|
artikel
|
| 262 |
Stereotactic ablative radiotherapy (SABR) for oligometastatic lymph node relapse in prostate cancer
|
Lopez Valcarcel, M.
|
|
|
|
S3 |
p. S281
|
artikel
|
| 263 |
Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis
|
Urbonas, V.
|
|
|
|
S3 |
p. S186
|
artikel
|
| 264 |
SunRISe-2: a phase 3, multicenter, randomized study evaluating the efficacy of TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy in participants with muscle-invasive urothelial carcinoma of the bladder
|
Williams, S.
|
|
|
|
S3 |
p. S376
|
artikel
|
| 265 |
SunRISe-1: phase 2b study of TAR-200 plus cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk non-muscle-invasive bladder cancer unresponsive to bacillus Calmette–Guérin who are ineligible for or decline radical cystectomy
|
Van Der Heijden, M.S.
|
|
|
|
S3 |
p. S389-S390
|
artikel
|
| 266 |
Surgery for stress urinary incontinence in males: Presurgical characteristics, associated complications, changes in continence parameters and quality of life evaluation
|
Medina Polo, J.
|
|
|
|
S3 |
p. S238
|
artikel
|
| 267 |
Survival and prognosis in patients with upper urothelial tract carcinoma after radical nephroureterectomy
|
Santiago Gonzalez, M.
|
|
|
|
S3 |
p. S401-S402
|
artikel
|
| 268 |
Systemic immune response after radiofrequency and cryoablation of localized renal cell carcinoma
|
Berkut, M.
|
|
|
|
S3 |
p. S179
|
artikel
|
| 269 |
Systemic therapy for metastatic renal cell carcinoma in the first-line setting: Network meta-analysis
|
Mori, K.
|
|
|
|
S3 |
p. S185
|
artikel
|
| 270 |
TALAPRO-3: A phase 3, double-blind, randomized study of enzalutamide (ENZA) plus talazoparib (TALA) vs placebo plus ENZA in patients (pts) with DDR gene mutated metastatic castration-sensitive prostate cancer (mCSPC)
|
Agarwal, N.
|
|
|
|
S3 |
p. S273
|
artikel
|
| 271 |
Targeting deubiquitinases with a selective and non-selective inhibitors as a potential therapeutic target in bladder cancer - initial in vitro evaluation
|
Nowak, L.
|
|
|
|
S3 |
p. S350-S351
|
artikel
|
| 272 |
Testicular disorders’ awareness and knowledge among Portuguese high-school students
|
Pereira, D.
|
|
|
|
S3 |
p. S341
|
artikel
|
| 273 |
Testicular Leydig cell tumors
|
Beniač, P.
|
|
|
|
S3 |
p. S237
|
artikel
|
| 274 |
Testis sparing surgery for small testicular masses: Functional and oncological outcomes
|
Kahraman, O.
|
|
|
|
S3 |
p. S245-S246
|
artikel
|
| 275 |
The clinical, radiological, pathological and oncological outcomes of prostate cancer patients undergoing PSMA PET/CT imaging for initial staging; comparing those with PSMA-avid Lesions suspicious for prostate cancer to those who have not
|
Veerman, A.N.
|
|
|
|
S3 |
p. S168
|
artikel
|
| 276 |
The correlation between GSTM1, NAT2 gene polymorphisms and some clinical characteristics of bladder cancer
|
Khuanbai, Y.
|
|
|
|
S3 |
p. S236
|
artikel
|
| 277 |
The diagnostic accuracy of Ga68 PSMA PET-CT on clinical lymph node staging before radical prostatectomy in patients with intermediate or high risk prostate cancer
|
Erdem, S.
|
|
|
|
S3 |
p. S134-S137
|
artikel
|
| 278 |
The diagnostic yield of systematic sampling in MRI/TRUS fusion biopsy
|
Ayerra Pérez, H.
|
|
|
|
S3 |
p. S230
|
artikel
|
| 279 |
The differentiation of benign from malignant solid renal masses with multi-parametric MRI: A retrospective study and proposed classification scheme
|
De Silva, S.
|
|
|
|
S3 |
p. S310-S311
|
artikel
|
| 280 |
The impact of MRI on management decisions in prostate cancer brachytherapy
|
Elangovan, A.
|
|
|
|
S3 |
p. S246
|
artikel
|
| 281 |
The impact of socio-economic deprivation on recovery following robotic assisted radical cystectomy
|
Hasan, W.
|
|
|
|
S3 |
p. S396
|
artikel
|
| 282 |
The Optilume drug coated balloon for recurrent anterior urethral strictures: ROBUST III study 2 year results
|
Elliott, S.
|
|
|
|
S3 |
p. S259-S260
|
artikel
|
| 283 |
The Optilume drug coated balloon for recurrent anterior urethral strictures: ROBUST I study 4 year results
|
DeLong, J.
|
|
|
|
S3 |
p. S258
|
artikel
|
| 284 |
The outcomes of active surveillance of prostate cancer in renal transplant patients: A propensity score matched comparison with a non-renal transplant cohort with prostate cancer
|
Soeterik, T.
|
|
|
|
S3 |
p. S258
|
artikel
|
| 285 |
The prognostic impact of intraductal carcinoma of the prostate: A systematic review and meta-analysis
|
Miura, N.
|
|
|
|
S3 |
p. S172
|
artikel
|
| 286 |
The results of tumor thrombus removal from the right atrium without extracorporeal circulation
|
Shchukin, D.
|
|
|
|
S3 |
p. S195
|
artikel
|
| 287 |
The role of 68Ga-PSMA-11 PET/CT in restaging high risk prostate cancer patients with PSA persistence after surgery
|
Bianchi, L.
|
|
|
|
S3 |
p. S219
|
artikel
|
| 288 |
The role of perilesional and magnetic resonance imaging-targeted biopsies to detect ISUP grade group upgrading at radical prostatectomy pathology
|
Hollans, M.
|
|
|
|
S3 |
p. S228
|
artikel
|
| 289 |
The role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography (PSMA PET/CT) in the selection of patients for salvage radiation therapy after radical prostatectomy
|
Meijer, D.
|
|
|
|
S3 |
p. S256
|
artikel
|
| 290 |
The role of radiation therapy to the primary tumor in patients with metastatic prostate cancer
|
González Calvo, E.
|
|
|
|
S3 |
p. S147
|
artikel
|
| 291 |
The significance of De-Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy
|
Quhal, F.
|
|
|
|
S3 |
p. S143
|
artikel
|
| 292 |
The use of frailty scores to predict tolerance to chemotherapy in patients with metastatic prostate cancer
|
Portner, R.
|
|
|
|
S3 |
p. S292
|
artikel
|
| 293 |
The use of nanofat grafting in the management of urethral and genital lichen sclerosus disease
|
Berdondini, E.
|
|
|
|
S3 |
p. S268
|
artikel
|
| 294 |
The use of urological Wise Choices in daily clinical practice: Results of a pilot evaluation study
|
Venderbos, L.D.F.
|
|
|
|
S3 |
p. S162-S163
|
artikel
|
| 295 |
Thulium fiber laser fulguration in combination with thulium “En bloc” technique resection of multifocal bladder tumor using SuperPulse Thulium Fiber Laser
|
Sytnik, D.
|
|
|
|
S3 |
p. S216
|
artikel
|
| 296 |
Time to cystectomy affects survival in initial pT1 non-muscle invasive bladder cancer
|
Culpan, M.
|
|
|
|
S3 |
p. S231-S232
|
artikel
|
| 297 |
Transition zone prostate cancer: Detection by second-look micro-ultrasonography after biparametric MRI
|
Cornud, F.
|
|
|
|
S3 |
p. S171
|
artikel
|
| 298 |
Treatment of EAU intermediate risk category non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations. A subgroup analysis of the ‘NIMBUS’ phase III clinical trial
|
Türkeri, L.
|
|
|
|
S3 |
p. S203-S204
|
artikel
|
| 299 |
Treatment patterns among men with metastatic Castration Resistant Prostate Cancer (mCRPC): Results from a European international study
|
Barata, P.
|
|
|
|
S3 |
p. S288-S289
|
artikel
|
| 300 |
Treatment patterns, outcomes, and costs associated with localized upper tract urothelial carcinoma
|
Fero, K.
|
|
|
|
S3 |
p. S363
|
artikel
|
| 301 |
Treatment trends among men with metastatic Castration Sensitive Prostate Cancer (mCSPC): Results from the European component of an international study
|
Barata, P.
|
|
|
|
S3 |
p. S290-S291
|
artikel
|
| 302 |
Tubulopapillary carcinomas of the kidney: Prognostic value of the distinction between type 1 and type 2
|
Saadi, A.
|
|
|
|
S3 |
p. S201-S203
|
artikel
|
| 303 |
Two-stage urethral substitution in failed hipospadias repair
|
Giunco, L.
|
|
|
|
S3 |
p. S269
|
artikel
|
| 304 |
Ultrasonography and magnetic resonance imaging are accurate for suspected penile fracture
|
Lee, W.G.
|
|
|
|
S3 |
p. S244-S245
|
artikel
|
| 305 |
Updated Overall Survival (OS) with atezolizumab (atezo) monotherapy vs. chemotherapy in untreated locally advanced or metastatic Urothelial Carcinoma (mUC) in the Phase III IMvigor130 study
|
Bamias, A.
|
|
|
|
S3 |
p. S201-S202
|
artikel
|
| 306 |
Upper urinary tract surveillance in patients with high risk non-muscle invasive bladder cancer managed with intravesical BCG
|
Baig, H.
|
|
|
|
S3 |
p. S234
|
artikel
|
| 307 |
Urethral reconstruction in kidney transplant patients
|
Vicéns-Morton, A.J.
|
|
|
|
S3 |
p. S250
|
artikel
|
| 308 |
Urethroplasty in complex infantile stricture
|
Medina Polo, J.
|
|
|
|
S3 |
p. S265
|
artikel
|
| 309 |
USPSTF 2012 Recommendation on prostate cancer screening and its unforeseen impact overseas
|
Silva, A.B.
|
|
|
|
S3 |
p. S169
|
artikel
|
| 310 |
Utility of Prostate Health Index (PHI) as a diagnostic parameter of prostate cancer and its impact on the need of a prostate biopsy
|
Aizpiri, L.
|
|
|
|
S3 |
p. S265
|
artikel
|
| 311 |
Validation of a computer application for non-muscular-infiltrating bladder cancer management
|
Ruíz Guerrero, E.
|
|
|
|
S3 |
p. S413
|
artikel
|
| 312 |
Ventral non-transecting vs. transecting techniques for short mid bulbar urethral strictures
|
Quereda-Flores, F.
|
|
|
|
S3 |
p. S241
|
artikel
|
| 313 |
When cost dictates treatment:
|
Esakia, T.
|
|
|
|
S3 |
p. S278
|
artikel
|
| 314 |
Why volumetric modulated arc therapy is better than three dimensions conformal radiotherapy in prostate cancer? Dosimetric analysis from a tertiary care hospital in Saudi Arabia
|
Maklad, A.
|
|
|
|
S3 |
p. S113
|
artikel
|
Tijdschrift beschrijving